Chapter 5: Actual and counterfactual smoking prevalence rates in the U.S. population via microsimulation

Risk Analysis

Volumn 32, Issue SUPPL.1, 2012, Pages

  Jeon, Jihyoun ^a   Meza, Rafael ^b   Krapcho, Martin ^c   Clarke, Lauren D ^d   Byrne, Jeff ^c   Levy, David T ^e,f  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

^d Cornerstone Systems Northwest Inc ^*  (United States)

^e PACIFIC INSTITUTE FOR RESEARCH AND EVALUATION   (United States)

^f UNIVERSITY OF BALTIMORE   (United States)

Author keywords

CISNET; Microsimulation; Smoking history generator; Smoking prevalence; Tobacco control

Indexed keywords

CISNET; MICROSIMULATION; SMOKING HISTORY GENERATOR; SMOKING PREVALENCE; TOBACCO CONTROL;

PHYSIOLOGY; RISK ANALYSIS; SAFETY ENGINEERING;

DISEASES;

CANCER; DISEASE PREVALENCE; HEALTH RISK; LIFE HISTORY; PUBLIC HEALTH; SMOKING; TEMPORAL PERIOD; TOBACCO;

ADOLESCENT; ADULT; AGED; ANAMNESIS; ARTICLE; COHORT ANALYSIS; COMPUTER PROGRAM; COMPUTER SIMULATION; FEMALE; HUMAN; LUNG TUMOR; MALE; MIDDLE AGED; PROBABILITY; SMOKING; SMOKING CESSATION; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMPUTER SIMULATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; PROBABILITY; SMOKING; SMOKING CESSATION; SOFTWARE; UNITED STATES;

UNITED STATES;

NICOTIANA TABACUM;

EID: 84864933057     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/j.1539-6924.2011.01775.x     Document Type: Article

References (16)

1. Holford TR, Clarke LD. Development of the counterfactual smoking histories used to assess the effects of tobacco control. Risk Analysis, 2012; 32(S1):S39-S50.
2. Anderson CM, Burns DM, Dodd KW, Feuer EJ. Birth cohort specific estimates of smoking behaviors for the U.S. population. Risk Analysis, 2012; 32(S1):S14-S24.
3. Moolgavkar SH, Knudson AG, Jr. Mutation and cancer: A model for human carcinogenesis. Journal of the National Cancer Institute, 1981; 66(6):1037-1052.
4. Hazelton WD, Clements MS, Moolgavkar SH. Multistage carcinogenesis and lung cancer mortality in three cohorts. Cancer Epidemiology, Biomarkers & Prevention, 2005; 14(5):171-1181.
5. Meza R, Hazelton WD, Colditz GA, Moolgavkar SH. Analysis of lung cancer incidence in the Nurses' Health and the Health Professionals' Follow-Up Studies using a multistage carcinogenesis model. Cancer Causes & Control, 2008; 19(3):317-328.
6. Knoke JD, Shanks TG, Vaughn JW, Thun MJ, Burns DM. Lung cancer mortality is related to age in addition to duration and intensity of cigarette smoking: An analysis of CPS I data. Cancer Epidemiology, Biomarkers & Prevention, 2004; 13(6):949-957.
7. Rosenberg MA, Feuer EJ, Yu B, Sun J, Henley SJ, Shanks TG, Anderson CM, McMahon PM, Thun MJ, Burns, DM. Cohort life tables by smoking status, removing lung cancer as a cause of death. Risk Analysis, 2012; 32(S1):S25-S38.
8. van de Mheen PJ, Gunning-Schepers LJ. Reported prevalences of former smokers in survey data: The importance of differential mortality and misclassification. American Journal of Epidemiology, 1994; 140(1):52-57.
9. Kemm J. A model to predict the results of changes in smoking behaviour on smoking prevalence. Journal of Public Health Medicine, 2003; 25(4):318-324.
10. McCarthy WJ, Meza R, Jeon J, Moolgavkar SH. Lung cancer in never smokers: Epidemiology and risk prediction models. Risk Analysis, 2012; 32(S1):S69-S84.
11. McWhorter WP, Boyd GM, Mattson ME. Predictors of quitting smoking: The NHANES I followup experience. Journal of Clinical Epidemiology, 1990; 43(12):1399-1405.
12. Gilpin EA, Pierce JP, Farkas AJ. Duration of smoking abstinence and success in quitting. Journal of the National Cancer Institute, 1997; 89(8):572-576.
13. Hughes JR, Peters EN, Naud S. Relapse to smoking after 1 year of abstinence: A meta-analysis. Addictive Behaviors, 2008; 33(12):1516-1520.
14. Matsumoto M, Nishimura T. Mersenne twister: A 623-dimensionally equidistributed uniform pseudo random number generator. ACM Transactions on Modeling and Computer Simulation, 1998; 8(1):3-30.
15. Hazelton WD, Jeon J, Meza R, Moolgavkar SH. The FHCRC lung cancer model. Risk Analysis, 2012; 32(S1):S99-S116.
16. Heidenreich WF, Luebeck EG, Moolgavkar SH. Some properties of the hazard function of the two-mutation clonal expansion model. Risk Analysis, 1997; 17(3):391-399.